Adicet Bio (LTS:0HX7) Accounts Payable & Accrued Expense : $10.02 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Adicet Bio Accounts Payable & Accrued Expense?

Adicet Bio's quarterly accounts payable & accrued expense declined from Sep. 2023 ($10.93 Mil) to Dec. 2023 ($9.55 Mil) but then increased from Dec. 2023 ($9.55 Mil) to Mar. 2024 ($10.02 Mil).

Adicet Bio's annual accounts payable & accrued expense increased from Dec. 2021 ($5.93 Mil) to Dec. 2022 ($11.51 Mil) but then declined from Dec. 2022 ($11.51 Mil) to Dec. 2023 ($9.55 Mil).

Adicet Bio Accounts Payable & Accrued Expense Historical Data

The historical data trend for Adicet Bio's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adicet Bio Accounts Payable & Accrued Expense Chart

Adicet Bio Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

2.51

3.45

5.93

11.51

9.55

Adicet Bio Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															11.39	11.79	10.93	9.55	10.02

Adicet Bio Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Adicet Bio (LTS:0HX7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adicet Bio Inc (LTS:0HX7) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ACET:USA 1IJA:Germany

Address

200 Clarendon Street, Floor 6, Boston, MA, USA, 02116

Website

https://www.adicetbio.com

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. The company operates and manages its business as one reportable and operating segment, which is the business of research and development of allogeneic immunotherapies for cancer and other diseases.

Adicet Bio (LTS:0HX7) Headlines

No Headlines